The burden and temporal trend of early onset pancreatic cancer based on the GBD 2021

Abstract In the context of the global increase in early-onset tumours, investigating the global disease burden caused by early-onset pancreatic cancer (EOPC) is imperative. Data on the burden of EOPC were obtained from the Global Burden of Disease Study 2021. A joinpoint regression model was used to...

Full description

Saved in:
Bibliographic Details
Main Authors: Zongbiao Tan, Yang Meng, Yanrui Wu, Junhai Zhen, Haodong He, Yu Pu, Jixiang Zhang, Weiguo Dong
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:npj Precision Oncology
Online Access:https://doi.org/10.1038/s41698-025-00820-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832572088004640768
author Zongbiao Tan
Yang Meng
Yanrui Wu
Junhai Zhen
Haodong He
Yu Pu
Jixiang Zhang
Weiguo Dong
author_facet Zongbiao Tan
Yang Meng
Yanrui Wu
Junhai Zhen
Haodong He
Yu Pu
Jixiang Zhang
Weiguo Dong
author_sort Zongbiao Tan
collection DOAJ
description Abstract In the context of the global increase in early-onset tumours, investigating the global disease burden caused by early-onset pancreatic cancer (EOPC) is imperative. Data on the burden of EOPC were obtained from the Global Burden of Disease Study 2021. A joinpoint regression model was used to analyse the temporal trend of the EOPC burden, and an age‒period‒cohort (APC) model was used to analyse the influence of age, period, and birth cohort on burden trends. Globally, the number of EOPC cases increased from 24,480 to 42,254, and the number of deaths increased from 17,193 to 26,996 between 1990 and 2021. The results of the APC model showed that the burden of EOPC increases with increasing age, whereas the variations in period and cohort effects exhibited a complex pattern across different sociodemographic index regions. Consequently, the disease burden of EOPC is increasing worldwide, highlighting the need for effective interventions.
format Article
id doaj-art-a5ada25b0d7443938323f5e4d2f74ba1
institution Kabale University
issn 2397-768X
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series npj Precision Oncology
spelling doaj-art-a5ada25b0d7443938323f5e4d2f74ba12025-02-02T12:06:32ZengNature Portfolionpj Precision Oncology2397-768X2025-01-019111110.1038/s41698-025-00820-0The burden and temporal trend of early onset pancreatic cancer based on the GBD 2021Zongbiao Tan0Yang Meng1Yanrui Wu2Junhai Zhen3Haodong He4Yu Pu5Jixiang Zhang6Weiguo Dong7Department of Gastroenterology, Renmin Hospital of Wuhan UniversityState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual ScienceDepartment of Gastroenterology, Renmin Hospital of Wuhan UniversityDepartment of General Practice, Renmin Hospital of Wuhan UniversityDepartment of Gastroenterology, Renmin Hospital of Wuhan UniversityDepartment of Gastroenterology, Renmin Hospital of Wuhan UniversityDepartment of Gastroenterology, Renmin Hospital of Wuhan UniversityDepartment of Gastroenterology, Renmin Hospital of Wuhan UniversityAbstract In the context of the global increase in early-onset tumours, investigating the global disease burden caused by early-onset pancreatic cancer (EOPC) is imperative. Data on the burden of EOPC were obtained from the Global Burden of Disease Study 2021. A joinpoint regression model was used to analyse the temporal trend of the EOPC burden, and an age‒period‒cohort (APC) model was used to analyse the influence of age, period, and birth cohort on burden trends. Globally, the number of EOPC cases increased from 24,480 to 42,254, and the number of deaths increased from 17,193 to 26,996 between 1990 and 2021. The results of the APC model showed that the burden of EOPC increases with increasing age, whereas the variations in period and cohort effects exhibited a complex pattern across different sociodemographic index regions. Consequently, the disease burden of EOPC is increasing worldwide, highlighting the need for effective interventions.https://doi.org/10.1038/s41698-025-00820-0
spellingShingle Zongbiao Tan
Yang Meng
Yanrui Wu
Junhai Zhen
Haodong He
Yu Pu
Jixiang Zhang
Weiguo Dong
The burden and temporal trend of early onset pancreatic cancer based on the GBD 2021
npj Precision Oncology
title The burden and temporal trend of early onset pancreatic cancer based on the GBD 2021
title_full The burden and temporal trend of early onset pancreatic cancer based on the GBD 2021
title_fullStr The burden and temporal trend of early onset pancreatic cancer based on the GBD 2021
title_full_unstemmed The burden and temporal trend of early onset pancreatic cancer based on the GBD 2021
title_short The burden and temporal trend of early onset pancreatic cancer based on the GBD 2021
title_sort burden and temporal trend of early onset pancreatic cancer based on the gbd 2021
url https://doi.org/10.1038/s41698-025-00820-0
work_keys_str_mv AT zongbiaotan theburdenandtemporaltrendofearlyonsetpancreaticcancerbasedonthegbd2021
AT yangmeng theburdenandtemporaltrendofearlyonsetpancreaticcancerbasedonthegbd2021
AT yanruiwu theburdenandtemporaltrendofearlyonsetpancreaticcancerbasedonthegbd2021
AT junhaizhen theburdenandtemporaltrendofearlyonsetpancreaticcancerbasedonthegbd2021
AT haodonghe theburdenandtemporaltrendofearlyonsetpancreaticcancerbasedonthegbd2021
AT yupu theburdenandtemporaltrendofearlyonsetpancreaticcancerbasedonthegbd2021
AT jixiangzhang theburdenandtemporaltrendofearlyonsetpancreaticcancerbasedonthegbd2021
AT weiguodong theburdenandtemporaltrendofearlyonsetpancreaticcancerbasedonthegbd2021
AT zongbiaotan burdenandtemporaltrendofearlyonsetpancreaticcancerbasedonthegbd2021
AT yangmeng burdenandtemporaltrendofearlyonsetpancreaticcancerbasedonthegbd2021
AT yanruiwu burdenandtemporaltrendofearlyonsetpancreaticcancerbasedonthegbd2021
AT junhaizhen burdenandtemporaltrendofearlyonsetpancreaticcancerbasedonthegbd2021
AT haodonghe burdenandtemporaltrendofearlyonsetpancreaticcancerbasedonthegbd2021
AT yupu burdenandtemporaltrendofearlyonsetpancreaticcancerbasedonthegbd2021
AT jixiangzhang burdenandtemporaltrendofearlyonsetpancreaticcancerbasedonthegbd2021
AT weiguodong burdenandtemporaltrendofearlyonsetpancreaticcancerbasedonthegbd2021